Business Development Asia LLC
South East Asian Health News
ISSUE 5, FEBRUARY 1998
MALAYSIA
Herbal Revival Sdn Bhd, the distributor of Thompson brand herbal supplements, has announced that it will invest over RM15m (US$4m) to build a new factory in Sungai Buloh. The factory is scheduled to come on line by 1999 and will enable Herbal Revival to realize revenues of RM200m (US$47m) annually. (January 7th 1998)
KPJ Healthcare Bhd has been granted approvals from Bank of Malaysia, the Foreign Investment Committee, and the Securities Commission for its latest corporate exercise. KPJ is set to acquire the entire interests of Pusat Pakar Tawakal for RM54m (US$13m), Puteri Specialist Hospital for RM59m (US$14m), and Kuantan Specialist Hospital for RM14m (US$3m). (December 27th 1997)
The Pantai Putri Hospital will invest RM1m (US$235,000) in order to provide three new hospital services. The investment will allow the hospital to offer neurosurgery, nephrology and colon/rectal services as of April 1998. The new services are expected to increase hospital revenue from RM6m (US$1.4m) to RM10m (US$2.4m). (January 24th 1998)
Remedi Pharmaceuticals Sdn Bhd, the main supplier to government hospitals, has been asked by the Ministry of Health to increase local sourcing of drugs. This will reduce the reliance on brand name imports and reduce costs. The Malaysian Treasury has approved an additional RM75m (US$18m) in funding to hospitals for 1998 to ensure that supplies of medicine are not depleted. (January 5th 1998) Quasar Carriage Sdn Bhd is contemplating two private hospital construction projects valued at RM600m (US$140m). The projects will be undertaken by Quasar and Ideal Medical Products SA, a French hospital management firm. The proposals involve both the construction of a turnkey hospital and the training of the medical staff. Quasar, primarily involved in the automotive industry, has described this potential venture as an attempt to diversify its business base. (January 16th 1998)
Tongkah Holdings Bhd is reviewing a group restructuring plan that would include the conversion of its subsidiary, Hospital Pantai Bhd (HPB), into a financial services arm. Under the proposal, Tongkah would acquire the healthcare assets and businesses of HPB for RM190m (US$45m) and buy 49% of Tongkah Medivest, while HPB would acquire the entire equity of Kestrel Securities, a stock brokerage, for RM200m (US$94m). Tongkah will not proceed with any restructuring until due diligence is completed in March. (January 9th 1998)
Recent News: Indonesia, Philippines, Thailand, Singapore, Vietnam, Regional Focus: The Future of Managed Care in South East Asia
Business Development Asia LLC, The Economist Building,
111 West 57th Street, Suite 405, New York, NY 10019
Tel (212) 265 5300 Fax (212) 265 4300 E-mail bdallc@aol.com
A limited liability company incorporated in the State of DelawareHome | Introduction | Services | Skills | Management | Contact | Newsletters